Panagora Asset Management Inc Puma Biotechnology, Inc. Transaction History

Panagora Asset Management Inc

$24.2 Billion
Q3 2025

A detailed history of Panagora Asset Management Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 165,921 shares of PBYI stock, worth $821,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,921

Previous 76,684 116.37%

Holding current value

$821,308

Previous $263,000 223.57%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.07 - $5.73 $273,957 - $511,328	89,237 Added 116.37%	165,921 $851,000
Q2 2025 Aug 13, 2025	BUY	$2.74 - $3.72 $210,114 - $285,264	76,684 New	76,684 $263,000
Q4 2024 Feb 13, 2025	SELL	$2.42 - $3.39 $104,495 - $146,380	-43,180 Reduced 42.32%	58,849 $179,000
Q3 2024 Nov 13, 2024	SELL	$2.25 - $4.03 $1,779 - $3,187	-791 Reduced 0.77%	102,029 $260,000
Q2 2024 Jul 29, 2024	BUY	$2.92 - $5.83 $300,234 - $599,440	102,820 New	102,820 $335,000

Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $336,426 - $676,955	-205,138 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.13 - $3.24 $15,050 - $22,893	7,066 Added 3.57%	205,138 $591,000
Q4 2021 Feb 10, 2022	BUY	$2.85 - $6.58 $6,435 - $14,857	2,258 Added 1.15%	198,072 $602,000
Q3 2021 Nov 10, 2021	SELL	$6.63 - $9.39 $39,203 - $55,523	-5,913 Reduced 2.93%	195,814 $1.37 Million
Q2 2021 Aug 11, 2021	SELL	$8.98 - $11.6 $125,791 - $162,492	-14,008 Reduced 6.49%	201,727 $1.85 Million
Q1 2021 May 12, 2021	SELL	$9.38 - $13.63 $51,665 - $75,074	-5,508 Reduced 2.49%	215,735 $2.1 Million
Q4 2020 Feb 10, 2021	SELL	$7.78 - $12.13 $564,182 - $879,631	-72,517 Reduced 24.69%	221,243 $2.27 Million
Q3 2020 Nov 13, 2020	SELL	$9.5 - $11.14 $21,878 - $25,655	-2,303 Reduced 0.78%	293,760 $2.96 Million
Q2 2020 Aug 12, 2020	BUY	$7.01 - $13.24 $1.03 Million - $1.95 Million	146,974 Added 98.58%	296,063 $3.09 Million
Q1 2020 May 14, 2020	BUY	$6.28 - $14.57 $568,415 - $1.32 Million	90,512 Added 154.52%	149,089 $1.26 Million
Q4 2019 Feb 12, 2020	BUY	$6.5 - $10.73 $18,063 - $29,818	2,779 Added 4.98%	58,577 $513,000
Q2 2019 Aug 09, 2019	BUY	$12.3 - $35.76 $686,315 - $2 Million	55,798 New	55,798 $709,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $90,876 - $211,457	-4,528 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$41.2 - $59.85 $1.47 Million - $2.14 Million	-35,782 Reduced 88.77%	4,528 $208,000
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $491,017 - $693,829	10,166 Added 33.72%	40,310 $2.38 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $126,922 - $211,005	2,126 Added 7.59%	30,144 $2.05 Million
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $2.63 Million - $3.71 Million	28,018	28,018 $2.77 Million

Others Institutions Holding PBYI

# of Institutions

135

Shares Held

35.2M

Call Options Held

264K

Put Options Held

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Puma Biotechnology, Inc. Transaction History